341 related articles for article (PubMed ID: 17967781)
1. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
[TBL] [Abstract][Full Text] [Related]
2. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
[TBL] [Abstract][Full Text] [Related]
5. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
Smith RS; Agata J; Xia CF; Chao L; Chao J
Life Sci; 2005 Apr; 76(21):2457-71. PubMed ID: 15763077
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway.
Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Noda A; Izawa H; Nagata K; Yokota M
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1164-71. PubMed ID: 17184496
[TBL] [Abstract][Full Text] [Related]
7. Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure.
Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Nishizawa T; Noda A; Izawa H; Nagata K; Murohara T; Yokota M
J Cardiovasc Pharmacol; 2006 Jun; 47(6):770-9. PubMed ID: 16810078
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
[TBL] [Abstract][Full Text] [Related]
9. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
Kaji H; Naito J; Inoue Y; Sowa H; Sugimoto T; Chihara K
Horm Metab Res; 2008 Nov; 40(11):746-51. PubMed ID: 18622892
[TBL] [Abstract][Full Text] [Related]
10. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
Chen LL; Yin H; Huang J
Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 and angiotensin networking in cardiac remodeling.
Rosenkranz S
Cardiovasc Res; 2004 Aug; 63(3):423-32. PubMed ID: 15276467
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
Kang BY; Mehta JL
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats.
Tsuruda T; Kato J; Hatakeyama K; Masuyama H; Cao YN; Imamura T; Kitamura K; Asada Y; Eto T
Cardiovasc Res; 2005 Mar; 65(4):921-9. PubMed ID: 15721873
[TBL] [Abstract][Full Text] [Related]
16. Wen-pi-tang-Hab-Wu-ling-san reduces ureteral obstructive renal fibrosis by the reduction of oxidative stress, inflammation, and TGF-beta/Smad2/3 signaling.
Jung KJ; Kim J; Park YK; Yoon YR; Park KM
Food Chem Toxicol; 2010 Feb; 48(2):522-9. PubMed ID: 19913069
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
Zhou G; Li X; Hein DW; Xiang X; Marshall JP; Prabhu SD; Cai L
J Am Coll Cardiol; 2008 Aug; 52(8):655-66. PubMed ID: 18702970
[TBL] [Abstract][Full Text] [Related]
18. Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling.
Ikeda Y; Aihara K; Yoshida S; Sato T; Yagi S; Iwase T; Sumitomo Y; Ise T; Ishikawa K; Azuma H; Akaike M; Kato S; Matsumoto T
Endocrinology; 2009 Jun; 150(6):2857-64. PubMed ID: 19196803
[TBL] [Abstract][Full Text] [Related]
19. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.
Hiraoka M; Nitta N; Nagai M; Shimokado K; Yoshida M
Life Sci; 2004 Jul; 75(11):1333-41. PubMed ID: 15234191
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
